Merle Turner
General Practice · Chandler, AZNPI 1659463552
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,695 of the $7,473 with a category attached, or 62.8%. Astellas Pharma US Inc accounts for 74.5% of it on its own, with 29 other manufacturers making up the rest. 2023 is the largest year on record at $5,820, 7.2 times the $808 reported in 2019. Among general practice clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $61.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$6K
- Novo Nordisk$264
- AstraZeneca$209
- Lilly USA, LLC$208
- Pfizer$147
- Lucid Diagnostics Inc.$107
- plus $970 from 24 others
Across 2 payments — averaging $3869.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$8K
What the payments were for
- Speaking & faculty fees$4,69563%
- Travel & lodging$4796%
- Food & beverage$2,27930%
- Entertainment$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $5,568 |
| Novo Nordisk | 18 | $264 |
| AstraZeneca | 17 | $209 |
| Lilly USA, LLC | 15 | $208 |
| Pfizer | 8 | $147 |
| Lucid Diagnostics Inc. | 3 | $107 |
| AbbVie(2 entities) | 7 | $106 |
| Abbott | 4 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $85 |
| GSK | 5 | $80 |
| Idorsia Pharmaceuticals US Inc | 5 | $77 |
| Amgen | 4 | $75 |
| Johnson & Johnson | 1 | $68 |
| Gilead | 2 | $55 |
| Amarin Pharma, Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Merck | 2 | $31 |
| Intuitive Surgical | 1 | $30 |
| Dexcom, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Optos, Inc. | 1 | $20 |
| Silk Road Medical, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Impulse Dynamics (USA) Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$5,523
How this compares
$7,473 in reported general payments places this provider in the 95th percentile of 1,998 general practice providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $678 |
| Atorvastatin Calcium | 33 | $540 |
| Gabapentin | 24 | $251 |
| Donepezil Hcl | 22 | $224 |
| Memantine Hcl | 11 | $157 |
| Levothyroxine Sodium | 14 | $155 |
| Escitalopram Oxalate | 13 | $147 |
Paid to pharmacies, not to this prescriber.
Other general practice in Chandler
- Thomas GiacobbiChandler$13K
- Joseph LuanChandler$8K
- Trupti NadkarniChandler$7K
- Curtis HamannPhoenix$1.9M
- Mehrdad MehranfarPhoenix$967K
- Trent SmallwoodTempe$481K
- Taylor KimApache Junction$389K
- Enrico DivitoScottsdale$289K
- Andrew EpsteinTucson$225K
- John YuOro Valley$209K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.